The only treatment for celiac disease is strict adherence to a gluten-free diet and, in an ideal world, compliance with this treatment would reverse all symptoms and physical attributes of the disease (i.e. damage to the small intestine). Unfortunately, that is not always the case; many patients continue to experience a wide range of symptoms and, in some cases, persistent intestinal damage in the form of villous atrophy (flattened villi). Researchers at Columbia University sought to more closely analyze these cases.
5/23/2017
Medication Use Associated with Persistent Villous Atrophy
Recent Posts
- Celiac Disease Foundation Brings Research and Patient Perspectives to ICDS 2026
- Teva Pharmaceuticals Announces Positive Phase 2a Results for Investigational Celiac Disease Treatment
- The Emerald Benefit: A Shining Example of Celiac Disease Advocacy
- Advocacy Spotlight: The Power of Youth Advocates
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Community Spotlight
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Impact Fund
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Recipes
- Research
- Research News
- Trending Topics
Marilyn's Message
3/18/2025
Read moreA Bold New Look for the Celiac Disease Foundation